| Christopher Wong, DPT | |
|
110 La Casa Via Ste 100, Walnut Creek, CA 94598-3000 | |
| (925) 935-4866 | |
| Not Available |
| Full Name | Christopher Wong |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 110 La Casa Via Ste 100, Walnut Creek, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053039156 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 302508 (California) | Primary |
| Provider Name | California Sports Physical Therapy Centers Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1467436329 PECOS PAC ID: 7618956889 Enrollment ID: O20050707001097 |
News Archive
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
Scientists in the United States have designed a device which is able to crawl across the surface of the heart and perform precision heart operations.
Using a set of different monoclonal antibodies, researchers determined different mutations in the SARS-CoV-2 spike protein that leads to resistance. Understanding these resistant mutations is important in developing effective therapeutic strategies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Wong, DPT 748 Sutton Dr, Walnut Creek, CA 94598-4664 Ph: (925) 588-1082 | Christopher Wong, DPT 110 La Casa Via Ste 100, Walnut Creek, CA 94598-3000 Ph: (925) 935-4866 |
News Archive
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
Scientists in the United States have designed a device which is able to crawl across the surface of the heart and perform precision heart operations.
Using a set of different monoclonal antibodies, researchers determined different mutations in the SARS-CoV-2 spike protein that leads to resistance. Understanding these resistant mutations is important in developing effective therapeutic strategies.
› Verified 1 days ago
Joley Ann Guevara, M.P.T Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1511 Treat Blvd, #100, Walnut Creek, CA 94598 Phone: 925-949-8911 | |
Karin Hess Bright, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 320 Lennon Ln, Walnut Creek, CA 94598 Phone: 925-906-2055 Fax: 905-906-2255 | |
Mr. Scott Turtle, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2625 Shadelands Dr, Walnut Creek, CA 94598 Phone: 925-939-8585 Fax: 925-933-2709 | |
Stacey Kegg, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 454 N Wiget Ln, Walnut Creek, CA 94598 Phone: 925-482-8111 | |
Caitlin Mondt, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2625 Shadelands Dr, Walnut Creek, CA 94598 Phone: 925-256-2107 | |
Sabrina Jajeh, Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 120 La Casa Via Ste 212, Walnut Creek, CA 94598 Phone: 925-939-8710 | |
Elizabeth Anne Flannery, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Andrea Dr, Walnut Creek, CA 94596 Phone: 925-705-7872 |